Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Optima Medical Innovations Corp TOKID


Primary Symbol: TOKIF

Optima Medical Innovations Corp. is a Canada-based multidisciplinary pain management with the focus on mental health and wellness. The Company is focused on offering medicine in individualized and targeted treatments. It is also engaged in the development of focused solutions, products and treatments for pain relief, wellness, and cancer. The Company's consumer products include Miraqell Immune Mushroom, Miraqell Day Cream, Miraqell Cleanser and Miraqell Eye Serum.


GREY:TOKIF - Post by User

Post by TraderJo2on Mar 29, 2019 9:27am
123 Views
Post# 29553260

How many countries are they entering??

How many countries are they entering??Let’s see, they’re supplying doctors in all Jack Nathan clinics in Canada, then Mexico, then US. Product line with Dr. Sanjay Gupta, supplying another major health clinic chain in Brazil, just had their first order in England, just doing a deal with Ireland and has Australia and China on their list of countries. Not to mention the stake in grower NGC back east and having the ex CEO of Nespresso along with all his connections, as their CEO. Then there’s the scientific research at three universities.

Personally, I would ignore/block anyone calling this company junk who cannot be bothered to read the press releases or read through the investor presentation available here: https://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1e7gpuq-TOKI+Corporate+Presentation+Dec%252c+2018+%283%29.pdf
<< Previous
Bullboard Posts
Next >>